Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial
ConclusionThis study has demonstrated that multiple infusions of mRNA electroporated HBV-specific TCR T cells were well-tolerated in patients with HBV-positive recurrent HCC post-liver transplant.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Databases & Libraries | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Infectious Diseases | Liver | Liver Cancer | Liver Transplant | Neurology | Study | Transplant Surgery | Transplants | Urology & Nephrology